A Legacy Built
Over 25 Years
From a single
idea in 2001
to a global
standard.
Founded in 2001 in Chuncheon, South Korea, Hugel Inc. began with a singular focus: botulinum toxin. From that foundation, Hugel built a record of remarkable growth — becoming the first South Korean BTx-A company to successfully enter the United States, Europe, and China simultaneously.
Today, Hugel offers a complete portfolio of aesthetic solutions: botulinum toxin, hyaluronic acid fillers, skin boosters, threads, and bio-cosmetics — what we call the "World's First Triangle Formation."
Small Bioventure Hugel Inc. is established in Seoul, South Korea
Hugel's flagship botulinumtoxinA receives Korean MFDS approval for medical and cosmetic use.
Hyaluronic acid filler The Chaeum® approved by the Korea FDA
Hugel's public listing on KOSDAQ accelerates global expansion. R&D investment sharpens.
Hugel's flagship neurotoxin becomes the botulinum toxin market leader in South Korea – and has maintained the position ever since
Hugel's flagship neurotoxin becomes the first South Korean botulinumtoxinA approved by China's NMPA – a defining moment for global expansion
Hugel's flagship neurotoxin receives marketing approval in Europe.
Hugel's flagship neurotoxin receives approval in Canada and Australia
Hugel's flagship neurotoxin receives U.S. FDA approval, making Hugel the first South Korean botulinumtoxinA company approved in US, China and EU.
A comprehensive K-Aesthetics portfolio across botulinum toxin, HA filler, skin booster, threads and cosmetics – distributed across 70+ countries
Global reach spanning 70+ countries
Authorized markets across the Americas, Europe and Asia-Pacific.